3,6-Dichloro-1,2,4,5-tetrazine, 95.0%, 50g

4-[3,5-Bis(trifluoromethyl)phenyl]-3-thiosemicarbazide, 2g

1-[isopropyl(methyl)amino]acetone hydrochloride, 95.0%, 25g

3-Hydroxy-2,2-dimethylpropyl 3-hydroxy-2,2-dimethylpropanoate, 98%, 25g

4-Bromo-2-methoxybenzonitrile, 95.0%, 10g

Butyrate de sodium, min 98%, pour synthèse, 500 g, emballage plastique.

N-Lauroyl-L-glutamic acid, 95.0%, 1g

8-Bromo-4-chloroquinazoline, 95.0%, 5g

4-Methoxy-1H-pyrrolo[3,2-c]pyridine, 95.0%, 250mg

4-Ethyl-2-nitroaniline, 97%, 250mg

Thalidomide-O-amido-PEG2-C2-NH2 (TFA), 500mg

2-chloro-6-nitro-3,4-dihydroquinazolin-4-one, 98%, 250mg

Methyl 5-bromo-2-fluoro-4-methylbenzoate, 97%, 250mg